News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical
BioLineRx Ltd. To Host Investor Breakfast In New York On December 3, 2015 11/25/2015
CTI BioPharma Announces Presentation Of Preclinical Data Demonstrating Potential Synergistic Combination Of Pacritinib And An EGFR Inhibitor In Targeting Brain Tumor Initiating Cells 11/23/2015
Can-Fite BioPharma (CFBI) Announces Compelling Pre-Clinical Data On CF102 In The Treatment Of Non-Alcoholic Steatohepatitis (NASH) 11/23/2015
Tocagen Inc. Presents Interim Data From Studies Evaluating Toca 511 & Toca FC At The Annual Meeting Of The Society For Neuro-Oncology (SNO) 11/23/2015
Athersys (ATHX)' MultiStem Promotes Recovery After Acute Spinal Cord Injury In Preclinical Study 11/19/2015
Memgen Announces Preclinical Results For Its ISF35 Cancer Immunotherapy With Checkpoint Inhibitors In Metastatic Melanoma 11/18/2015
DBV Tech To Present Preclinical Data On Its Viaskin Technology For RSV Vaccination At The 2015 RSV Vaccines For The World Meeting 11/18/2015
Regen BioPharma Submits Response To FDA Questions On Hemaxellerate Investigational New Drug Application 11/17/2015
Profectus BioSciences, Inc. Presents Preclinical Data Demonstrating That A Single Dose Of Multi-Component Vaccine Provides Complete Protection Against Zaire And Sudan Species Of Ebola Virus And Marburg Virus 11/17/2015
MGB Biopharma Limited Successfully Completes Feasibility Study With Topical Formulation Of Its Lead Antibacterial MGB-BP-3 11/17/2015
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 2015 Novel Cancer Therapeutics Summit 11/17/2015
Regen BioPharma Initiates NR2F6 T Cell Immunotherapy Preclinical Program With Dr. Santosh Kesari, Director Of Neuro-Oncology At John Wayne Cancer Institute 11/12/2015
Blueprint Medicines (BPMC) To Present Preclinical Data At 2015 American Society of Hematology Annual Meeting Demonstrating Anti-Tumor Activity Of BLU-285 In A Model Of Acute Myeloid Leukemia 11/12/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Enters Into Sponsored Research Agreement With University of Texas MD Anderson Cancer Center To Advance Stem-To-T-Cell Program 11/12/2015
Novogen Limited (NVGN) Release: Preclinical Studies Justify Mode Of Delivery And Dosing Regimen For Anisina 11/11/2015
Protalex, Inc. (PRTX) Announces Presentation Of Preclinical Data With PRTX-100 Supporting Treatment Of Immune Thrombocytopenia At The American Society of Hematology 57th Annual Meeting And Exposition 11/11/2015
Opexa Therapeutics (OPXA) Announces Supportive Preclinical Study Results For Its Neuromyelitis Optica (NMO) Program 11/11/2015
PHARNEXT's Pleodrug PXT-864 Demonstrates Positive Effects In Parkinson's Disease Preclinical Data Published In Nature's Scientific Reports 11/10/2015
Blueprint Medicines (BPMC) Highlights Advances In Preclinical Discovery Efforts 11/10/2015
Threshold Pharmaceuticals, Inc. (THLD) Release: Preclinical Studies Find That Tarloxotinib May Overcome Resistance To EGFR Tyrosine Kinase Inhibitors 11/10/2015
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 2015 Novel Cancer Therapeutics Summit 11/10/2015
Sunesis (SNSS) Presents Preclinical Data From Its BTK And PDK1 Inhibitor Programs At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/9/2015
Immunomedics, Inc. (IMMU) Announces Sacituzumab Govitecan Is Synergistic With Chemotherapeutics That Target Cell Division In Triple-Negative Breast Cancer 11/9/2015
Curis, Inc. (CRIS) Collaborator Aurigene Presents Preclinical Data From Oral Small Molecule PD-L1/VISTA And IRAK4 Programs At AACR-NCI-EORTC International Conference 11/9/2015
Compelling Preclinical Data On Sun BioPharma's SBP-101 Presented At The 2015 American Pancreatic Association (APA) Annual Meeting 11/9/2015
Samumed Announces Successful Modulation Of The Wnt Pathway For Potential Cartilage Regeneration 11/9/2015
OncoMed Pharmaceuticals, Inc. (OMED) Presents Immuno-Oncology Data For Combined Blockade Of DLL4, VEGF And PD1 At The Society For Immunotherapy Of Cancer Annual Meeting 11/9/2015
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-1158 At The 2015 AACR-NCI-EORTC International Conference 11/6/2015
Kolltan Pharmaceuticals Inc. Presents KTN3379 Preclinical Data At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/6/2015
Apexigen Presents Preclinical Data From Novel Immuno-Oncology Candidate APX005M At SITC 2015 Meeting 11/6/2015
Preclinical Data Of Xencor's XmAb Bispecific Technology To Be Presented At Upcoming American Society of Hematology Annual Meeting 11/6/2015
Infinity Pharmaceuticals Inc. (INFI) Provides Company Update And Reports Third Quarter 2015 Financial Results 11/6/2015
Celldex (CLDX) Presents Varlilumab Mechanism Data At SITC Annual Meeting 2015 11/6/2015
Biothera's Imprime PGG And Monoclonal Antibody Therapy Alleviates Immune Suppression In Tumor Microenvironment And Increases Cancer Cell Killing 11/6/2015
Biothera’s Imprime PGG And Anti-Angiogenic Antibodies Work In Concert To Re-Orient The Immune Microenvironment To Support Cancer Killing, Study Finds 11/6/2015
Acetylon Pharmaceuticals’s Oral Selective HDAC6 Inhibitor ACY-241 Enhances Anti-Tumor Activity Of Paclitaxel In Preclinical Solid Tumor Models 11/6/2015
bluebird bio (BLUE) To Present LentiGlobin BB305 Clinical Data And Bb2121 Preclinical Data At Annual Meeting Of The American Society of Hematology 11/5/2015
Virttu Biologics Shows Robust Evidence Of Immunological Activity In Mesothelioma Patients Following SEPREHVIR Administration Results To Be Presented At Society For ImmunoTherapy Of Cancer (SITC) 11/5/2015
Fate Therapeutics (FATE) To Present Preclinical Data For Protmune At American Society of Hematology 2015 Annual Meeting 11/5/2015
Syros Pharmaceuticals To Present Preclinical Data On First-In-Class Selective CDK7 Inhibitor Program At American Society of Hematology Annual Meeting 11/5/2015
Intensity Therapeutics, Inc. Preclinical Results Show Anti-Cancer Synergy Of INT230-6 With Anti-PD-1 Compounds 11/5/2015
Nordic Nanovector: Abstract Describing Preclinical Research With Betalutin Accepted For Presentation At The 57Th American Society of Hematology Annual Meeting 11/5/2015
Kadmon Corporation Presents Preclinical Data On Immuno-Oncology Anti-PD-L1/IL-15 Fusion Protein At AACR-NCI-EORTC Symposium 11/4/2015
ImaginAb, Inc. Presents Precision Immuno-Imaging Data At Society For Immunotherapy Of Cancer (SITC) 2015 Annual Meeting 11/3/2015
Immune Design Corporation (IMDZ) Presents Preclinical Data On G100 And ZVex In Combination With Check Point Inhibitors At The 2015 Society For Immunotherapy Of Cancer Annual Meeting 11/3/2015
Angion Biomedica Corp. To Present Clinical And Preclinical Data At The Upcoming American Society of Nephrology Conference In San Diego 11/2/2015
Asana Biosciences To Present Pre-Clinical Data For A Novel Dual Inhibitor Of B-Raf And PI3 Kinase Pathway At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/2/2015
Curis, Inc. (CRIS) Announces Presentation Of Preclinical Data From Small Molecule PD-L1/VISTA And IRAK4 Programs At The AACR-National Cancer Institute-EORTC International Conference 11/2/2015
ApeX Therapeutics To Present APX3330's Ability To Reduce Tumor Volume And Metastases And Potentiate Efficacy Of Gemcitabine In Preclinical Models Of Pancreatic Cancer At The AACR-National Cancer Institute-EORTC International Conference 11/2/2015
Hutchison China MediTech (Chi-Med) Release: Sulfatinib Clinical Results And Fruquintinib-Savolitinib Combination Preclinical Results To Be Presented At The 2015 AACR-National Cancer Institute-EORTC Molecular Targets And Cancer Therapeutics Conference 10/30/2015
Kolltan Pharmaceuticals Inc. To Present Preclinical Data At The 30th Annual Society For Immunotherapy Of Cancer (SITC) Conference And Preclinical Data At The AMRI (AMRI)-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 10/30/2015
Aduro Biotech (ADRO) And Protein Potential LLC Present Data Demonstrating Novel Vaccine Offers 100% Protection In Malarial Model 10/28/2015
Threshold Pharmaceuticals, Inc. (THLD) Announces Preclinical Data Presentations On Tarloxotinib At The 2015 AACR-NCI-EORTC Meeting 10/27/2015
Clasado And University of Oxford Demonstrate Latest Series Of Effects Of Advanced Prebiotic On Neuro-Inflammation And Anxiety In Pre-Clinical Study 10/27/2015
Nordic Nanovector: Poster Presentation Of Preclinical Studies Comparing Betalutin With LU-177 Chimeric Anti-CD37 Antibody Radionuclide Conjugate 10/27/2015
Verastem (VSTM) To Present Preclinical Data At The 2015 EORTC-National Cancer Institute-AACR International Conference On Molecular Targets And Cancer Therapeutics 10/27/2015
H3 Biomedicine Publishes Preclinical Data Describing Mechanistic Insights Into Splicing Factor Mutations In Multiple Cancers 10/26/2015
Morphotek Inc. Presents Preclinical Findings At ESGO 19 On The Potential Immunosuppressive Effects Of The CA125 Tumor Antigen On Farletuzumab, An Investigational Anti-Folate Receptor Alpha Antibody 10/26/2015
Loxo Oncology (LOXO) Announces Broad Pipeline Update At AACR-National Cancer Institute-EORTC, Including New LOXO-101 Phase 1 Data 10/26/2015
Innovus Pharma Announces Sensum+ To Directly Increase Sensitivity In Pre-Clinical Studies Supporting Its Mechanism Of Action And The Human Use Experience 10/21/2015
Biscayne Pharmaceuticals Release: New Study Published In PNAS Shows Biscayne's GHRH Agonists Could Increase The Feasiblity Of Beta Cell Transplants To Treat Type 1 Diabetes 10/20/2015
RXi Pharma (RXII) Announces Remarkable And Positive Results With Its Novel Self-Delivering RNAi Platform: Potent Reduction Of Long Non-Coding Rnas Demonstrated In Collaboration With Biogazelle 10/20/2015
DelMar Pharmaceuticals Presents Positive Preclinical Data On VAL-083 As A Promising Treatment For Ovarian Cancer 10/19/2015
Probiodrug AG Presented Data On Its pglu-3 Abeta Monoclonal Antibody At Neuroscience 2015, Chicago 10/19/2015
REPLICor Inc. Presents Updated Mechanistic Data And Pre-Clinical Interferon-Free Combination Treatment Data In HBV And HBV / HDV Co-Infection 10/15/2015
OncoQR’s Breast Cancer Vaccine Successfully Completes Pre-Clinical Proof-of-Concept Study 10/15/2015
ArQule, Inc. (ARQL) Announces Publication Of Manuscript Highlighting Activity Of AKT Inhibitor ARQ 092 And Next Generation AKT Inhibitor ARQ 751 In Oncology 10/15/2015
Kuros Biosurgery AG To Present Positive kur-115 Pre Clinical Data For Interbody Spinal Fusion Treatment At The 2015 North American Spine Society 10/15/2015
Alnylam (ALNY) Demonstrates Continued Commitment To Transthyretin-Mediated Amyloidosis Patients With Advancement Of ALN-TTRsc02, An Investigational RNAi Therapeutic With Potential For Low Volume, Once Quarterly, Subcutaneous Dose Regimen 10/14/2015
MediciNova, Inc. To Present Preclinical Data On MN-166 (Ibudilast) At The 26th International Symposium On ALS/MND In Orlando, FL 10/14/2015
Eli Lilly (LLY) And ImaginAb, Inc. Announce Preclinical Immuno-Oncology Collaboration 10/13/2015
Addex Therapeutics (ADXN.SW)' ADX71441 Demonstrates Robust Efficacy In Multiple Preclinical Models Of Alcohol Use Disorder 10/13/2015
Celsion (CLSN) Announces Impressive Preclinical Data For Its GEN-1 IL-12 Immunotherapy In Combination With Avastin And Doxil For Ovarian Cancer 10/12/2015
Proteostasis Therapeutics, Inc. Presents Preclinical Data For Its CFTR Amplifier Program At The 29th Annual North American Cystic Fibrosis Conference 10/12/2015
Ansun BioPharma Announces Successful Treatment With DAS181 In A Patient With Severe Influenza And Parainfluenza At IDSA Meeting 10/9/2015
Fibrocell Science, Inc. And Intrexon Announce Poster Presentation On FCX-007 For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa (RDEB) At American Society of Human Genetics Annual Meeting 10/8/2015
Regulus (RGLS) To Present Additional Preclinical Data Supporting RG-012 As A Novel microRNA Therapeutic In Development For Alport Syndrome At American Society of Nephrology's Kidney Week 2015 10/6/2015
Protalix Biotherapeutics, Inc. (PLX) To Explore Non Alcoholic Steato Hepatitis (NASH) As An Indication For Its PRX 106 Oral Anti TNF 10/5/2015
Parion Sciences Announces Upcoming Presentations Of Data At The North American Cystic Fibrosis Conference Being Held October 8 Through 10, 2015 10/5/2015
NYU Langone Medical Center Release: Experimental Cancer Drug Shows Therapeutic Promise In Mouse Models Of Multiple Sclerosis 10/1/2015
Acceleron Pharma Presents Preclinical Data For ACE-083 And ACE-2494 At The 20th International Annual Congress Of The World Muscle Society 10/1/2015
ProQR Therapeutics B.V. (PRQR) An Investor And Analyst Event And Pre-Clinical Data Presentations For QR-010 For Cystic Fibrosis At Two Upcoming Scientific Conferences 10/1/2015
UbiVac Announces Collaboration With Johnson & Johnson Innovation (JNJ) To Develop And Test, In Preclinical Studies, A Vaccine To Intercept Oral Cancer 9/29/2015
Cellectar Biosciences  (NVLT) Announces Pricing Of $3.3 Million Financing 9/28/2015
Kolltan Pharmaceuticals Inc. Announces Presentation Of KTN0158 Preclinical Data At The ESMO Cancer Conference 2015 9/28/2015
Palatin Tech (PTN) Release: Preclinical Data On PL-3994 For Heart Failure And Resistant Hypertension Presented At 2015 Heart Failure Society Of America Annual Meeting 9/28/2015
Regen BioPharma Announces Positive Results From GLP Safety Study For HemaXellerate 9/28/2015
Microlin Bio Announces Positive Results From Preclinical Lung Cancer Study Using Lead Anti-Microrna Candidate 9/25/2015
Macrophage Therapeutics Produces First Two Immunoconstructs 9/25/2015
Syros Pharmaceuticals Announces New Publication Highlighting The Strong Potential Of CDK7 Inhibition In Difficult-To-Treat Cancer 9/25/2015
Celator Pharmaceuticals, Inc. Announces Positive Results From R&D Programs 9/24/2015
NanoBio Corporation's Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine 9/23/2015
Addex Therapeutics (ADXN.SW) ADX71149 Demonstrates Synergistic Efficacy With Levetiracetam In Preclinical Models Of Epilepsy 9/23/2015
Scholar Rock Presents First Data For Niche Modulator Inhibiting Myostatin Activation And Announces SRK-015 As Lead Drug Program 9/23/2015
Corbus To Present Additional Data On The Effects Of Resunab In The Treatment Of Pulmonary Infection And Inflammation In Pre-Clinical Models Of Cystic Fibrosis 9/22/2015
Nektar Therapeutics (NKTR) Presents Data Demonstrating That NKTR-214, A CD122-Biased Immunostimulatory Cytokine, Induces Durable And Specific Anti-Tumor Immunity As A Single-Agent And When Combined With Checkpoint Inhibitors In Preclinical Models 9/22/2015
Matinas BioPharma Presents Pre-Clinical Data Showing Anti-Bacterial Activity Of MAT2501 - Encochleated Amikacin - Against Mycobacterium Avium Lung Infections At ICAAC/ICC 2015 9/21/2015
BerGenBio AS Release: BGB324 Enhances Immune Checkpoint Inhibitor Efficacy In Preclinical Cancer Models 9/21/2015
Summit Therapeutics Presents New Positive Preclinical Data On Novel C. difficile Antibiotic SMT19969 At ICAAC 2015 9/18/2015
OncoMed Pharmaceuticals, Inc. (OMED) Presents Immuno-Oncology Data For GITRL-Fc Candidate At The Inaugural International Cancer Immunotherapy Conference 9/17/2015
Aeglea Announces Publication Of Nonclinical Data On Lead Molecule, AEB1102, In Human Molecular Genetics 9/16/2015
Novavax (NVAX) RSV F Vaccine Is Highly Immunogenic With Robust Transplacental Antibody Transfer In Preclinical Maternal Immunization Model 9/16/2015
Idera Pharmaceuticals, Inc. (IDRA) Presents New Intratumoral IMO-2125 Preclinical Data At CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference 9/16/2015
Vical  (VICL) To Present Preclinical Data At ICAAC 2015 Meeting For Its Novel Antifungal Drug Candidate VL-2397 9/15/2015
VBI Vaccines Promotes Dr. David E. Anderson To Chief Scientific Officer 9/14/2015
WMIS Young Investigator Of The Year Demonstrates New Preclinical Models Of Central Nervous System Tuberculosis For Early Detection Of Brain Inflammation In Children 9/14/2015
Arrowhead Research Corporation (ARWR) Nominates ARC-HIF2 As First RNAi Therapeutic Candidate Using Extrahepatic DPC Delivery System 9/11/2015
Parion Sciences Release: CLEAN-CF Clinical Trial Expanded To Include Pediatric Cystic Fibrosis Population 9/10/2015
Asterias Biotherapeutics Announces Publication Of Preclinical Data That Supports The Safety And Use Of AST-OPC1 As A Treatment For Spinal Cord Injury (SCI) 9/9/2015
Regeneron (REGN) Scientists Discover Key to Why Some People's Muscles Suddenly Turn into Bone 9/8/2015
Debiopharm And Solid Biosciences, LLC, Announce A Collaboration To Explore The Use Of Alisporivir (Debio 025) In Muscular Dystrophy 9/8/2015
NIH To Evaluate Berg's Drug For The Treatment Of Kidney Cancer 9/8/2015
Trevena, Inc. (TRVN) Announces Presentations At PAINWeek 2015 9/8/2015
Karyopharm (KPTI) Advancing Neuroprotective SINE Compounds in Amyotrophic Lateral Sclerosis (ALS) 9/3/2015
BioTime (BTX) Chief Executive Officer Dr. Michael D. West To Be Keynote Speaker At Stem Cells & Regenerative Medicine Congress 2015 9/1/2015
Blueprint Medicines (BPMC) To Present Preclinical Data On BLU-554 And On Novel Drug Target At International Liver Cancer Association 9th Annual Conference 9/1/2015
Regen BioPharma Develops BORIS Gene Silencing Based Treatment For Unresectable Liver Cancer 8/31/2015
Novogen Limited (NVGN) Announces The Outcome Of A Comprehensive Science Review 8/31/2015
Portola To Present Preclinical Data With Andexanet Alfa And Factor Xa Inhibitor Edoxaban At European Society of Cardiology Congress 2015 8/28/2015
greenovation Biotech GmbH Release: Fabry Enzyme Replacement Therapy (ERT) Based On Mannose-Mediated Cellular Uptake Shows Encouraging Preclinical Results That Allow Start Of Early Clinical Trials 8/27/2015
Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant To Develop Its Proteoglycan Mimetic Therapeutics To Reduce Vascular Access Failures In ESRD 8/26/2015
Audentes Therapeutics Receives Orphan Drug Designation For AT001 For The Treatment Of X-Linked Myotubular Myopathy In The U.S. And Europe 8/26/2015
Mirati Therapeutics  (MRTX) To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer 8/24/2015
Celator Pharmaceuticals, Inc. Appoints Michael R. Dougherty As Executive Chairman Of Board Of Directors 8/24/2015
Regen BioPharma BORIS Gene Silencing Technology Successfully Utilized By Independent Researchers To Kill Breast Cancer And Colon Cancer Stem Cells 8/24/2015
Janus Biotherapeutics Enters Collaboration With Roche (RHHBY) In Autoimmune Diseases 8/20/2015
Inovio Pharma (INO) DNA Vaccine Protects 100% Against Deadly MERS Virus In Non-Human Primates 8/20/2015
Visterra, Inc. Announces Publication Of Data Demonstrating The Effectiveness Of VIS410 Against Seasonal And Potential Pandemic Influenza Strains 8/18/2015
Champions Oncology, Inc. (CSBR) Files Patents For Use Of PDX Platform In Immune-Oncology 8/17/2015
Veloxis Pharmaceuticals A/S (VELO) Envarsus XR Granted Orphan Drug Status By FDA For Kidney Transplant Rejection Prophylaxis 8/17/2015
Trevena, Inc. (TRVN) Reports Second Quarter 2015 Financial Results And Provides A Corporate Update 8/11/2015
Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2015 Operational And Financial Results 8/11/2015
Calithera Biosciences, Inc. (CALA) Reports Second Quarter 2015 Financial Results And Recent Highlights 8/11/2015
KannaLife Sciences, Inc. Discusses Orphan Drug Opportunity For KLS-13019 8/11/2015
Gliknik Licensee Pfizer (PFE) Receives Orphan Drug Designation From FDA For Drug Candidate Directed Towards Rare Neurological Disorder 8/10/2015
Celsion Corporation (CLSN) Reports Second Quarter 2015 Financial Results And Provides Business Update 8/10/2015
Regen BioPharma Progresses In FDA Responses To dCellVax Clinical Trial Questions 8/10/2015
NanoViricides, Inc. (NNVC.PK) Reports That The Dramatic Effects Of Its Topical Anti-Herpes Treatment Were Reproduced Once Again In An Animal Model In A Different Laboratory 8/10/2015
Immune Design Corporation (IMDZ) And Merck & Co. (MRK) To Collaborate On Combination Trials Of Two Immune Design Immunotherapies With Merck's KEYTRUDA For Non-Hodgkin's Lymphoma And Melanoma 8/10/2015
Chimerix (CMRX) Announces Second Quarter 2015 Financial Results 8/6/2015
Amarantus BioSciences, Inc. Announces A New Eltoprazine Publication Confirming The Long-Term Efficacy And Elucidating The Mechanism Of Action In PD-LID 8/5/2015
bluebird bio (BLUE) Announces Participation At The 2015 Wedbush PacGrow Healthcare Conference 8/5/2015
Aratana Therapeutics (PETX) Announces Positive Pilot Field Study For AT-016 7/31/2015
GenKyoTex S.A. ’s NOX1&4 Inhibitor Strategy In Liver Fibrosis Supported By New Preclinical Results 7/30/2015
Inovio Pharmaceuticals (INO)' DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge 7/29/2015
Cardax Product Candidates Demonstrate Superior Bioavailability Vs. Microalgal Astaxanthin In Monkey Study 7/29/2015
Oragenics, Inc. (OGEN) Reports Positive In Vivo Antibiotic Efficacy Data In Critical Animal Study 7/29/2015
Ciclofilin Pharmaceuticals' Lead Antiviral Drug Reduces Liver HBV DNA 7/28/2015
Yabao Pharmaceuticals Starts Preclinical Studies On Sepsis Treatment 7/28/2015
EnzymeBioSystems Release: Amooranin Preclinical Sample Batch Completed 7/28/2015
Pernix (PTX) Releases Positive In Vitro Abuse Deterrent Data For Third Generation Extended Release Hydrocodone ZX007 7/27/2015
Matinas BioPharma Announces Abstract On Pharmacokinetics And Efficacy Of Encochleated Atovaquone In Murine Model Of Pneumocystis Accepted For Oral Presentation At IDWeek 2015 7/27/2015
New Data Show Pluristem Therapeutics (PSTI)s PLX Cells Regulate The Immune System 7/27/2015
Yissum Ltd. Introduces A Novel Technology For Drug Screening And Testing Of Orphan Diseases Without Utilizing Animal Models 7/27/2015
Chimerix (CMRX) Announces Positive Topline Results From Brincidofovir Pivotal Study In Animal Model For Smallpox 7/23/2015
Regen BioPharma Successfully Completes In Life Portion Of Experiments Requested By FDA For HemaXellerate Pre-Clinical Study 7/21/2015
BioRestorative To Evaluate Cell Delivery Technology To Advance Metabolic Program Towards Human Trials 7/20/2015
NeuroPhage Pharmaceuticals, Inc.'s NPT088 Universally Targets Misfolded Proteins In Preclinical Studies Highlighted In Oral Session At The Alzheimer's Association International Conference 7/20/2015
TREVENTIS Pre Clinical Candidate TRV 101 Demonstrates Significant Reduction In Both Amyloid Beta And Tau Toxic Aggregates In Animal Models Of Alzheimer's Disease 7/20/2015
Fox Chase Cancer Center To Conduct ONC201 Dose Intensification Trial 7/20/2015
Radius Health (RDUS) Today Announced Preclinical Data For Its Investigational Drug RAD1901 In Combination With CDK And Mtor Inhibitors 7/16/2015
Novogen Limited (NVGN) Release: Anisina Receives Orphan Drug Designation From FDA For Neuroblastoma 7/16/2015
Regen BioPharma Presents Preclinical Proof-Of-Concept Of Diffronc Effectiveness At The International Society for Stem Cell Research Annual Meeting 7/14/2015
Novogen Limited (NVGN) Release: Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness In Childhood Cancer 7/14/2015
RestorGenex Announces Positive 3-D Cancer Cell Culture Data For RES-529, A TORC1/TORC2 Inhibitor 7/14/2015
Scholar Rock Presents Preclinical Data For First Demonstration Of Novel Pharmacological Approach To Targeting The Tgfß1 Latent Complex 7/14/2015
Summit Therapeutics Publishes Preclinical Data On Disease-Modifying Potential Of Utrophin Modulation In DMD 7/13/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400 7/9/2015
CEVEC Pharma's CAP(R)Go Derived Recombinant Placental Human Alkaline Phosphatase Shows Superior Results In A Preclinical Study 7/6/2015
Navidea (NAVB) Reports Clinical Data Demonstrating Manocept Agent Localizes In Multiple KS Lesions 7/2/2015
Can-Fite BioPharma (CFBI)'s CF602 Sexual Dysfunction Drug Backed By New Preclinical Data Progresses Towards An IND 6/29/2015
Celladon (CLDN) Lays Off More Staff, Considers Liquidation in Wake of Gene Therapy Failure 6/29/2015
Preclinical Data On NeuralStem Inc.'s Genetically Modified HK532-IGF-1 Stem Cells In Alzheimer's Disease Presented At International Society for Stem Cell Research Annual Meeting 6/26/2015
Ciclofilin Pharmaceuticals' HBV Drug Demonstrates Anti-Fibrotic Activity 6/24/2015
Neurotrope To Conduct Study On Niemann-Pick Type C, A Devastating Rare Pediatric Disease 6/24/2015
Catalyst Biosciences Announces Positive Results From A Phase 1 Clinical Trial Of Its Next Generation Coagulation Factor VIIa In Patients With Hemophilia A Or B And Preclinical Results From Its Factor IX And Factor Xa Programs 6/24/2015
Blueprint Medicines (BPMC) Debuts Preclinical Data For First-In-Class RET Drug Candidate 6/22/2015
BioBlast Pharma (ORPN) Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Read-Through Platform In Spinal Muscular Atrophy (SMA) 6/22/2015
Cristal Therapeutics' Proprietary CriPec Nanomedicine Platform And Promising Preclinical Data Highlighted In Three Recent Publications 6/22/2015
Cour Pharmaceuticals Releases Data On Potential Breakthrough Treatment For Celiac Disease 6/22/2015
RestorGenex Announces Presentation Of Prostate Cancer Data On RES-529, A Dual TORC1/TORC2 Inhibitor 6/19/2015
Spark Therapeutics (ONCE) To Present With Pfizer (PFE) Preclinical Data On Their Lead SPK-FIX Product Candidate For Hemophilia B At The 2015 International Society Of Thrombosis And Haemostasis Congress In June 6/19/2015
International AIDS Vaccine Initiative Release: AIDS Vaccine Candidate Successfully 'Primes' Immune System In Animal Models 6/19/2015
BioBlast Pharma (ORPN) To Present Preclinical Proofs Of Concept In Spinal Muscular Atrophy And Friedreich's Ataxia At Two Leading Scientific Meetings In June 6/18/2015
Cardax Pharmaceuticals Inc. Initiates Monkey Study To Compare Bioavailability Of Patented Consumer Health Product Candidate CDX-085 To Microalgal Astaxanthin 6/18/2015
FORMA Therapeutics, Inc. Achieves Clinical Candidate Licensing Milestone For An Epigenetic Compound In Strategic Alliance With Celgene (CELG) 6/17/2015
ImmunoGen (IMGN)’s IMGN529 For B-Cell Malignancies Demonstrates Synergistic Activity With Rituximab In Preclinical Models Of Non-Hodgkin Lymphoma 6/17/2015
Tolero Pharmaceuticals Presents Positive Preclinical Data That Inhibition Of AXL Kinase Restores Tumor Response To Retinoic Acid 6/16/2015
Tolero Pharmaceuticals Presents Positive Preclinical Data On Hepcidin Inhibition For The Treatment Of Anemia Associated With Chronic Disease 6/16/2015
Bionomics Limited (BNO.AX) Files Patent For Use Of BNC105 In Combination With PD-1 And CTLA-4 Immuno-Oncology Antibodies 6/15/2015
Tikcro Technologies To Proceed With CTLA4 And PD1 Antibody Generation Plan 6/15/2015
Acceleron Pharma Announces Publication In Cancer Research Demonstrating Dalantercept Prevents Metastases In Preclinical Studies Of Breast Cancer 6/15/2015
Protalix Biotherapeutics, Inc. (PLX) Announces AIR Dnase Data Presented At The 38th European Cystic Fibrosis Conference 6/12/2015
Cytori Therapeutics, Inc. (CYTX)’ Preclinical Data For The Treatment Of Thermal Injury Published In The Journal Burns 6/10/2015
Despite Promising AbbVie (ABBV) Partnerships, Neurocrine Biosciences (NBIX) Halts Two Clinical Trials 6/9/2015
Oncolytics Biotech Inc. (ONC.TO) Provides Update At AGM On Planned Registration Program For REOLYSIN 6/9/2015
Fibrocell Science, Inc. And Intrexon Corporation Announce Positive In Vitro Pre-Clinical Data For FCX-007 For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa (RDEB) At European Society Of Human Genetics 6/8/2015
Presentations On Two Novel Zealand Pharma  (ZEAL.CO) Preclinical Peptide Therapeutics As Possible Approaches For The Treatment Of Type 2 Diabetes And Obesity At The American Diabetes Association's 74th Scientific Sessions 6/8/2015
Mundipharma EDO GmbH Data Confirm EDO-S101 Is Effective In Preclinical Models Of Human Glioblastoma 6/3/2015
MGB Biopharma Limited Succeeds In Developing An IV Formulation Of MGB-BP-3 For The Treatment Of Systemic Susceptible And Resistant Gram-Positive Hospital-Acquired Infections 6/2/2015